Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma

Alan Hauser, Sunil W. Dutta, Timothy N. Showalter, Jason P. Sheehan, Surbhi Grover, Daniel Trifiletti

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective To identify if facility type and/or facility volume impact overall survival (OS) following diagnosis of glioblastoma (GBM). We also sought to compare early post-surgical outcomes based on these factors. Methods The National Cancer Database was queried for patients with GBM diagnosed from 2004 to 2013 with known survival. Patients were grouped based on facility type and facility volume. Multivariable analyses were performed to investigate factors associated OS following diagnosis and Chi-square tests were used to compare early post-surgical outcomes. Results 89,839 patients met inclusion criteria. Factors associated with improved OS on multivariable analysis included younger patient age, female gender, race, lower comorbidity score, higher performance score, smaller tumor size, unifocal tumors, MGMT hypermethylation, fully resected tumors, radiotherapy, and chemotherapy (each p <.001). Also, OS was improved among patients treated at centers averaging at least 30.2 cases per year (HR 0.948, compared to <7.4 cases/year, p <.001), and patients treated at Academic/Research programs had improved survival compared to those treated at Comprehensive Community Cancer programs (HR 1.069, p <.001) and Integrated Network Cancer programs (HR 1.126, p <.001). Similarly, Academic/Research programs and high volume centers demonstrated improved 30- and 90-day morality as well as 30-day readmission rates (p <.001). Conclusions This study suggests that patients treated in Academic/Research programs and high patient-volume centers have increased survival and more favorable early-postsurgical outcomes. The extent to which differences in patient populations, socioeconomic factors, and/or provider expertise play into this cause will be areas of future research.

Original languageEnglish (US)
Pages (from-to)103-110
Number of pages8
JournalJournal of Clinical Neuroscience
Volume47
DOIs
StatePublished - Jan 1 2018

Fingerprint

Glioblastoma
Survival
Neoplasms
Research
Chi-Square Distribution
Comorbidity
Radiotherapy
Databases
Drug Therapy

Keywords

  • Academic
  • GBM
  • Morality
  • NCDB
  • Postoperative
  • Survival

ASJC Scopus subject areas

  • Surgery
  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma. / Hauser, Alan; Dutta, Sunil W.; Showalter, Timothy N.; Sheehan, Jason P.; Grover, Surbhi; Trifiletti, Daniel.

In: Journal of Clinical Neuroscience, Vol. 47, 01.01.2018, p. 103-110.

Research output: Contribution to journalArticle

Hauser, Alan ; Dutta, Sunil W. ; Showalter, Timothy N. ; Sheehan, Jason P. ; Grover, Surbhi ; Trifiletti, Daniel. / Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma. In: Journal of Clinical Neuroscience. 2018 ; Vol. 47. pp. 103-110.
@article{f998fc7cdbf64024b4edf48d042f7400,
title = "Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma",
abstract = "Objective To identify if facility type and/or facility volume impact overall survival (OS) following diagnosis of glioblastoma (GBM). We also sought to compare early post-surgical outcomes based on these factors. Methods The National Cancer Database was queried for patients with GBM diagnosed from 2004 to 2013 with known survival. Patients were grouped based on facility type and facility volume. Multivariable analyses were performed to investigate factors associated OS following diagnosis and Chi-square tests were used to compare early post-surgical outcomes. Results 89,839 patients met inclusion criteria. Factors associated with improved OS on multivariable analysis included younger patient age, female gender, race, lower comorbidity score, higher performance score, smaller tumor size, unifocal tumors, MGMT hypermethylation, fully resected tumors, radiotherapy, and chemotherapy (each p <.001). Also, OS was improved among patients treated at centers averaging at least 30.2 cases per year (HR 0.948, compared to <7.4 cases/year, p <.001), and patients treated at Academic/Research programs had improved survival compared to those treated at Comprehensive Community Cancer programs (HR 1.069, p <.001) and Integrated Network Cancer programs (HR 1.126, p <.001). Similarly, Academic/Research programs and high volume centers demonstrated improved 30- and 90-day morality as well as 30-day readmission rates (p <.001). Conclusions This study suggests that patients treated in Academic/Research programs and high patient-volume centers have increased survival and more favorable early-postsurgical outcomes. The extent to which differences in patient populations, socioeconomic factors, and/or provider expertise play into this cause will be areas of future research.",
keywords = "Academic, GBM, Morality, NCDB, Postoperative, Survival",
author = "Alan Hauser and Dutta, {Sunil W.} and Showalter, {Timothy N.} and Sheehan, {Jason P.} and Surbhi Grover and Daniel Trifiletti",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jocn.2017.10.087",
language = "English (US)",
volume = "47",
pages = "103--110",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Impact of academic facility type and volume on post-surgical outcomes following diagnosis of glioblastoma

AU - Hauser, Alan

AU - Dutta, Sunil W.

AU - Showalter, Timothy N.

AU - Sheehan, Jason P.

AU - Grover, Surbhi

AU - Trifiletti, Daniel

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective To identify if facility type and/or facility volume impact overall survival (OS) following diagnosis of glioblastoma (GBM). We also sought to compare early post-surgical outcomes based on these factors. Methods The National Cancer Database was queried for patients with GBM diagnosed from 2004 to 2013 with known survival. Patients were grouped based on facility type and facility volume. Multivariable analyses were performed to investigate factors associated OS following diagnosis and Chi-square tests were used to compare early post-surgical outcomes. Results 89,839 patients met inclusion criteria. Factors associated with improved OS on multivariable analysis included younger patient age, female gender, race, lower comorbidity score, higher performance score, smaller tumor size, unifocal tumors, MGMT hypermethylation, fully resected tumors, radiotherapy, and chemotherapy (each p <.001). Also, OS was improved among patients treated at centers averaging at least 30.2 cases per year (HR 0.948, compared to <7.4 cases/year, p <.001), and patients treated at Academic/Research programs had improved survival compared to those treated at Comprehensive Community Cancer programs (HR 1.069, p <.001) and Integrated Network Cancer programs (HR 1.126, p <.001). Similarly, Academic/Research programs and high volume centers demonstrated improved 30- and 90-day morality as well as 30-day readmission rates (p <.001). Conclusions This study suggests that patients treated in Academic/Research programs and high patient-volume centers have increased survival and more favorable early-postsurgical outcomes. The extent to which differences in patient populations, socioeconomic factors, and/or provider expertise play into this cause will be areas of future research.

AB - Objective To identify if facility type and/or facility volume impact overall survival (OS) following diagnosis of glioblastoma (GBM). We also sought to compare early post-surgical outcomes based on these factors. Methods The National Cancer Database was queried for patients with GBM diagnosed from 2004 to 2013 with known survival. Patients were grouped based on facility type and facility volume. Multivariable analyses were performed to investigate factors associated OS following diagnosis and Chi-square tests were used to compare early post-surgical outcomes. Results 89,839 patients met inclusion criteria. Factors associated with improved OS on multivariable analysis included younger patient age, female gender, race, lower comorbidity score, higher performance score, smaller tumor size, unifocal tumors, MGMT hypermethylation, fully resected tumors, radiotherapy, and chemotherapy (each p <.001). Also, OS was improved among patients treated at centers averaging at least 30.2 cases per year (HR 0.948, compared to <7.4 cases/year, p <.001), and patients treated at Academic/Research programs had improved survival compared to those treated at Comprehensive Community Cancer programs (HR 1.069, p <.001) and Integrated Network Cancer programs (HR 1.126, p <.001). Similarly, Academic/Research programs and high volume centers demonstrated improved 30- and 90-day morality as well as 30-day readmission rates (p <.001). Conclusions This study suggests that patients treated in Academic/Research programs and high patient-volume centers have increased survival and more favorable early-postsurgical outcomes. The extent to which differences in patient populations, socioeconomic factors, and/or provider expertise play into this cause will be areas of future research.

KW - Academic

KW - GBM

KW - Morality

KW - NCDB

KW - Postoperative

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85032796180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032796180&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2017.10.087

DO - 10.1016/j.jocn.2017.10.087

M3 - Article

C2 - 29113851

AN - SCOPUS:85032796180

VL - 47

SP - 103

EP - 110

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

ER -